(Q73149881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

main subject

lymphoblastic leukemia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Entz-Werlé N

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Eyer D

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Pencreac'h E

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Schneider A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Falkenrodt A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Uettwiller F

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Babin A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Voegeli AC

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Lessard M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Gaub MP

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Lutz P

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Oudet P

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

532-540

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12646941%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402774

1 November 2019

exact match

0 references

cites work

Acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Treatment of childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

1 reference

7 January 2021

The mechanisms of DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Human TOP3: a single-copy gene encoding DNA topoisomerase III

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

One-megabase sequence analysis of the human immunoglobulin lambda gene locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Novel HeLa topoisomerase II is the II beta isoform: complete coding sequence and homology with other type II topoisomerases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Topoisomerase II and the response to antileukemic therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Evidence for a critical role of DNA topoisomerase IIalpha in drug sensitivity revealed by inducible antisense RNA in a human leukaemia cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

DNA topoisomerase II mutations and resistance to anti-tumor drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Secondary leukemias induced by topoisomerase-targeted drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Topoisomerase II inhibitor-related acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Microsatellite instability and allelic imbalance in primary and secondary colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Acquisition of multiple copies of a mutant topoisomerase IIalpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Determination of DNA topoisomerase II in newly diagnosed childhood acute lymphoblastic leukemia by immunocytochemistry and RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021

Glucocorticoid induced apoptosis in leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402774

7 January 2021